NYU Langone offers an Innovations in Treatment Delivery of Empirically Supported Assessment & Treatment for Challenges in ...
What if a single test could simultaneously contribute to the diagnosis, characterization, and treatment guidance of childhood ...
TipRanks on MSN
Eli Lilly, Incyte report results from BRAVE-AA-PEDS trial
New results from Eli Lilly (LLY) and Incyte (INCY) showed once-daily, oral baricitinib 4 mg helped the majority of adolescent patients with severe ...
A Concordia-led research team has created one of the first reference charts showing how children's adipose (fat) and muscle ...
Positive results from the DESTINY-Breast11 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) followed by paclitaxel, trastuzumab and pertuzumab (THP) in the neoadjuvant setting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback